| Literature DB >> 28805984 |
Malak M Khalifeh1,2, Nicholas D Moore1, Pascale R Salameh2.
Abstract
Regulations usually distinguish between prescription-only (POM) and over-the-counter (OTC) medicines. The former requires medical prescription; the latter are available for SM of common minor or easily treated ailments. However, in the Eastern Mediterranean countries, theoretical prescription medicines can easily be purchased without a prescription, as self-medication (SM) resulting in potential misuse and unnecessary risk for patients. The magnitude of this activity is uncertain. The aim of this article, therefore, is to undertake a comprehensive review to identify the different types of medicines that can easily be purchased as SM in Middle East and recognized as misused. An extensive review of the published literature (1990-2015) was conducted using Pubmed, web of science, Cochrane, and Google Scholar databases, for OTC medicine misuse in the Middle East. A total of 72 papers were identified. Medicines involved in misuse included: codeine containing products, topical anesthetics, topical corticosteroids, antimalarial, and antibiotics. Self-medication misuse of medicines seemed widespread. Individual treatment patterns were not clearly identified. Studies were not standardized, limiting the comparability between studies and the estimation of the scale of misuse. Pharmacists, friends, or parents were found to be the main sources of SMs. Knowledge and attitudes are an important contributing factor in the misuse of these medications. Strategies and interventions to limit misuse were rarely identified in literature. In conclusion, a massive problem involving a range of medicines was found in Middle East. Standardization of studies is a prerequisite to the understanding and prevention of misuse of self-medication.Entities:
Keywords: Eastern Mediterranean countries; Middle East; Prescription medicines; Self-medication; misuse; over-the-counter
Year: 2017 PMID: 28805984 PMCID: PMC5684864 DOI: 10.1002/prp2.323
Source DB: PubMed Journal: Pharmacol Res Perspect ISSN: 2052-1707
Figure 1Selection of articles.
Types of drugs misused in the retrieved publications
| Types of Drugs misused | Number of papers (n) | Countries | Prevalence of SM % | Study participants | Reference |
|---|---|---|---|---|---|
| Analgesics (including codeine‐containing medicines) | 4 | Iran | 28.7% | 564 University students | Sarahroodi et al. ( |
| 60% | 210 University and school students | Sedighi et al. ( | |||
| Saudi Arabia | 504 University students | Ibrahim et al. ( | |||
| Pakistan | 55.4% | 1380 Community participants | Qazi et al. ( | ||
| Jordan | 32% | 393 Pharmacists | Albsoul‐Younes et al. ( | ||
| Tramadol | 2 | Iran | 56%4.8% | 162 Pharmacy customers 1894 School students | Zabihi et al. ( |
| Antibiotics | 38 | Iran | 35.8% | 320 University staff | Askarian and Maharlouie ( |
| 42.2% | 195 University members | Sarahroodi et al. ( | |||
| 43% | 272 Patients at clinics | Jafari et al. ( | |||
| 53% | 153 University females | Sarahroodi and Arzi ( | |||
| 57.6% | 572 Community participants | Heidarifar et al. ( | |||
| Jordan | 40.7% | 477 Patients at clinics | Sawair et al. ( | ||
| 46.3 | 480 pharmacy customers | Al‐Bakri et al. ( | |||
| 62% | 37 Community participants | Darwish et al. ( | |||
| 32% | 174 Patients at clinics | Scicluna et al. ( | |||
| 59.1% | 1141 Community participants | Shehadeh et al. ( | |||
| N/A | 1091 Pharmacy customers | Alzoubi et al. ( | |||
| 68.8% | 679 University students | Suaifan et al. ( | |||
| N/A | 393 Pharmacists | Albsoul‐Younes et al. ( | |||
| Lebanon | 32% | 110 Pharmacists | Farah et al. ( | ||
| 42% | 340 Pharmacy customers | Cheaito et al. ( | |||
| 37% | 119 Patients at clinics | Scicluna et al. ( | |||
| Pakistan | 71.4% | 780 University and school students | Aslam et al. ( | ||
| N/A | 1342 Households | Sturm et al. ( | |||
| 30% Pharyngitis 23% Gastroenteritis | 851 Community participants | Qazi et al. ( | |||
| 25% storage | 158 Households | Nasir et al. ( | |||
| 35.2% | 572 University students | Zafar et al. ( | |||
| 10.8% storage | 158 Households | Haider and Thaver ( | |||
| Saudi Arabia | 48% | 353 School teachers | Belkina et al. ( | ||
| 11.6% for children | 610 Community Parents | Abobotain et al. ( | |||
| 5% | 1596 University and school students 88 Pharmacists | Almalak et al. ( | |||
| Syria | 85% | 365 Community participants | Barah and Goncalves ( | ||
| N/A | 200 pharmacists | Al‐Faham et al. ( | |||
| UAE | 40.2 | 300 University students | Suleiman and Rubian ( | ||
| 46% | 860 Community parents | Abasaeed et al. ( | |||
| 11.4% | 324 School students | Shehnaz et al. ( | |||
| Iraq | 26% | 300 Households | Jassim ( | ||
| Egypt | 23.3% | 884 Pharmacy customers | Sabry et al. ( | ||
| 30% | 300 Patients at clinics | Scicluna et al. ( | |||
| Kuwait | 27.50% | 680 Community participants | Awad and Aboud ( | ||
| Libya | 43% | 363 University students | Ghaieth et al. ( | ||
| 48% | 286 Patients at clinics | Scicluna et al. ( | |||
| Oman | 67% | 718 Community participants | Jose et al. ( | ||
| Yemen | 78.2% | 367 School teachers | Belkina et al. ( | ||
| 60% | 2000 Patients at clinics | Mohanna ( | |||
| Sudan | 48.10% | 1750 Households | Awad et al. ( | ||
| Tunisia | 20.00% | 264 Patients at clinics | Scicluna et al. ( | ||
| Antimalarial | 2 | Sudan | 43.4% | 1750 Households | Awad et al. ( |
| Yemen | Abdo‐Rabbo ( | ||||
| Topical Anesthetics | 2 | Iran | 80.5% | 390 Welders | Sharifi et al. ( |
| Saudi Arabia | Risco and Millar ( | ||||
| Topical Corticosteroids | 1 | Iraq | 7.90% | 1780 Patients at clinics | Al‐Dhalimi and Aljawahiry ( |
| Cough/cold products | 3 | Pakistan | N/A | 864 University students | Bano et al. ( |
| Jordan | N/A | 393 Pharmacists | Albsoul‐Younes et al. ( | ||
| Palestine | N/A | 864 University students | Sweileh et al. ( | ||
| Decongestants | 1 | Jordan | N/A | 393 Pharmacists | Albsoul‐Younes et al. ( |
| Laxatives | 1 | Palestine | N/A | 97 Pharmacists | Sweileh et al. ( |
| Sedatives/Hypnotics and Benzodiazepines | 3 | Jordan | N/A | 393 Pharmacists | Albsoul‐Younes et al. ( |
| United Arab Emirates | N/A | 324 School students | Shehnaz et al. ( | ||
| Jordan | N/A | 393 Pharmacists | Albsoul‐Younes et al. ( |
Percentage of antibiotic compliance in the retrieved publications
| Countries | % Antibiotic Compliance | Study Setting | Reference |
|---|---|---|---|
| Jordan | 39% | 800 University students | Suaifan et al. ( |
| 40% | 508 Community participants | Darwish et al. ( | |
| Kuwait | 64% | 680 Community participants | Awad and Aboud ( |
| Iran | 37.10% | 542 Community participants | Heidarifar et al. ( |
| 26.80% | 564 University students | Sarahroodi and Arzi ( | |
| Libya | 86% | 363 University students | Ghaieth et al. ( |
| Oman | 29% | 718 Community participants | Jose et al. ( |
| 56% | 400 School teachers | Belkina et al. ( | |
| Pakistan | 42% | 780 University and school students | Aslam et al. ( |
| Saudi Arabia | 71.30% | 300 Households | Abobotain et al. ( |
| 61% | 1200 School teachers | Belkina et al. ( | |
| United Arab Emirates | 75% | 385 Women in clinics | Suleiman and Rubian ( |
Sources for Self‐Medication
| Sources of SM | Number of articles (n) | Country, % | References |
|---|---|---|---|
| Pharmacists | 23 | Egypt, 13.1%, 30% | Scicluna et al. ( |
| Iran 18.6%, 30%, 44.8%, 61.2% | Sarahroodi and Arzi ( | ||
| Jordan 14.2%, 23.1%, 30%, 53.6%, 30% | Al‐Bakri et al. ( | ||
| Lebanon 29.8%, 35% | Cheaito et al. ( | ||
| Libya 74%, 12% | Scicluna et al. ( | ||
| Pakistan 33.49% | Qazi et al. ( | ||
| Yemen 55.1% | Belkina et al. ( | ||
| Saudi Arabia 21.6%, 74% | Alghanim ( | ||
| Emirates 21.4%, 16.3%, 74% | Shehnaz et al. ( | ||
| Iraq 18.6% | Al‐Dhalimi and Aljawahiry ( | ||
| Yemen N/A | Abdo‐Rabbo ( | ||
| Tunisia 12% | Scicluna et al. ( | ||
| Parents/Friends | 19 | Iran 0.6%, 6%, 54.7%, 40.1% | Sharifirad et al. ( |
| Jordan 51.8%, 10.3%, 12% | Sawair et al. ( | ||
| Libya 26%, 11% | Scicluna et al. ( | ||
| Pakistan 20.09% | Qazi et al. ( | ||
| Yemen 7.3% | Belkina et al. ( | ||
| Saudi Arabia 19.3%, 20.3% | Belkina et al. ( | ||
| Emirates 20.2% | Shehnaz et al. ( | ||
| Iraq 20.7% | Al‐Dhalimi and Aljawahiry ( | ||
| Yemen N/A | Abdo‐Rabbo ( | ||
| Kuwait N/A | Abahussain et al. ( | ||
| Egypt 11% | Scicluna et al. ( | ||
| Lebanon 10% | Scicluna et al. ( | ||
| Tunisia 13% | Scicluna et al. ( | ||
| Physician advice or health professionals | 5 | Lebanon 50.8% | Cheaito et al. ( |
| Emirates 25.8% | Suleiman and Rubian ( | ||
| Jordan 21.9% | Yousef et al. ( | ||
| Iran 27.2% | Sharifi et al. ( | ||
| Iraq 11.4% | Al‐Dhalimi and Aljawahiry ( | ||
| Dr. over phone | 1 | Jordan 37.5% | Suaifan et al. ( |
| Leftover | 10 | Iran 38.2%, 47.8%, 52% | Sarahroodi and Arzi ( |
| Iraq 45% | Jassim ( | ||
| Jordan 46%, 49%, 60% | Shehadeh et al. ( | ||
| Lebanon 19.4% | Cheaito et al. ( | ||
| Emirates 1.1%, 28% | Suleiman and Rubian ( | ||
| Stores at home for future use | 2 | Jordan 50% | Scicluna et al. ( |
| Tunisia 40% | Scicluna et al. ( | ||
| Libya 59% | Scicluna et al. ( | ||
| Lebanon 60% | Scicluna et al. ( | ||
| Egypt 40% Iraq 23% | Scicluna et al. ( | ||
| Self present based on: previous experience of symptoms or disease or knowledge | 6 | Emirates 27% | Suleiman and Rubian ( |
| Iran 30.1% 48.5%, 75% | Sarahroodi et al. ( | ||
| Jordan 27%, 53.1% | Yousef et al. ( | ||
| Yemen 17.1% | (Belkina et al. | ||
| Saudi Arabia 31.6% | Belkina et al. ( | ||
| Previous treatment | 3 | Jordan 36.1%, 40% | Scicluna et al. ( |
| Tunisia 45% | Scicluna et al. ( | ||
| Libya 48% | Scicluna et al. ( | ||
| Lebanon 88% | Scicluna et al. ( | ||
| Egypt 40% | Scicluna et al. ( | ||
| Iran N/A | Jalilian et al. ( | ||
| Previous suggestion by physician or Dr. always prescribe the same antibiotic | 2 | Iran 32.6% | Sarahroodi et al. ( |
| Lebanon 43% | Scicluna et al. ( | ||
| Egypt 11% | Scicluna et al. ( | ||
| Tunisia 21% | Scicluna et al. ( | ||
| Jordan 10% | Scicluna et al. ( | ||
| Libya 30% | Scicluna et al. ( | ||
| Old prescription | 3 | Yemen 20.6% | Belkina et al. ( |
| Saudi Arabia 27.5%, 50.8% | Alghanim ( | ||
| Emirates 26% | Mohanna ( | ||
| Doctor prescription to friend | 1 | Emirates 3.4% | Suleiman and Rubian ( |